Neurocrine Biosciences Inc. (NBIX)
NBIX trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$135.13
-4.41% on the day
Market cap
$13.7B
Large cap
Revenue · 2025
$2.9B
+21.4% on 2024
Net income · 2025
$478.6M
16.7% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | NBIX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 1996 |
| SEC CIK | 0000914475 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.9B |
| Net income | $478.6M |
| Operating income | $619.1M |
| Net margin | 16.7% |
| Operating margin | 21.6% |
| Revenue growth | +21.4% |
| Cash | $713.0M |
| Total assets | $4.6B |
| P/E (computed) | 28.7× |
| P/S (computed) | 4.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 10-K | 2026-02-11 |
| Latest quarterly / interim | 10-Q | 2026-07-31 |
| Latest current report | 8-K | 2026-09-28 |
| Latest proxy | DEFA14A | 2026-04-15 |
Source: SEC EDGAR submissions feed, 1,003 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.3% |
| 1 month | -9.4% |
| 3 months | -20.8% |
| Year to date | -4.2% |
| 1 year | -1.0% |
| From 52-week high | -26.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| EXEL | Exelixis Inc. | $59.51 | -0.52% | $14.7B |
| HALO | Halozyme Therapeutics Inc. | $109.62 | -1.31% | $12.4B |
| TECH | Bio-Techne Corp | $72.48 | -0.11% | $11.4B |
| PCVX | Vaxcyte Inc. | $66.80 | -5.45% | $10.5B |
| IBRX | ImmunityBio Inc. | $9.80 | -3.16% | $10.4B |
| TWST | Twist Bioscience Corporation | $151.33 | -0.35% | $10.0B |
| KRYS | Krystal Biotech Inc. | $321.16 | -3.29% | $9.5B |
| QGEN | Qiagen N.V. Common Shares | $45.44 | +0.29% | $9.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier